SCHEMBL24601804

SCHEMBL24601804

c1ccc(-c2cc(-c3ccccc3)c(-c3ccc4c(c3)c3c5c6ccccc6n6c7ccc(-c8c(-c9ccccc9)cc(-c9ccccc9)cc8-c8ccccc8)cc7c(c7c8ccccc8n4c73)c56)c(-c3ccccc3)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CHEK1 O14757 4/20 0.33
WEE1 P30291 4/20 0.33
GPR84 Q9NQS5 1/20 0.31
NPY5R Q15761 1/20 0.31
HTR6 P50406 1/20 0.31
HPRT1 P00492 1/20 0.31
PTPN1 P18031 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30
RET P07949 1/20 0.30
SRC P12931 1/20 0.30
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601799 0.93 HSD17B10 (0.34) HSD17B10CHEK1WEE1GPR84HTR6
SCHEMBL24601801 0.90 GPR84 (0.37) TSPOHSD17B10GPR84
SCHEMBL24601649 0.90 HSD17B10 (0.36) TSPOHSD17B10CHEK1WEE1HTR6
SCHEMBL24601430 0.90 HSD17B10 (0.36) TSPOHSD17B10CHEK1WEE1HTR6
SCHEMBL22178499 0.88 TSPO (0.43) TSPOHSD17B10HTR6PSEN1PSEN2
SCHEMBL22178510 0.88 TSPO (0.43) TSPOHSD17B10HTR6PSEN1PSEN2
SCHEMBL24601509 0.87 HSD17B10 (0.34) TSPOHSD17B10CHEK1WEE1HTR6
SCHEMBL22178719 0.87 TSPO (0.37) TSPOHSD17B10HTR6PIK3CA
SCHEMBL24601508 0.87 TSPO (0.37) TSPOHSD17B10HTR6PIK3CA
SCHEMBL22178583 0.86 HSD17B10 (0.37) TSPOHSD17B10CHEK1WEE1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 TSPO 3404/4885HSD17B10 4661/4885CHEK1 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.